CGRP therapies: What do we know?
Elevated levels of calcitonin gene-related peptide (CGRP) have previously been found in the external jugular venous blood during migraine attacks.1 It is therefore speculated that CGRP may play a significant and causative role in their induction.1 Following these findings, CGRP‑blocking therapies have emerged as a potential preventive measure against migraine during the la
Login to register to read this article
If you do not have a Log in, please register to be part of a big community, experience premium content and stay informed about exclusive professional events.
Log InNot registered yet? Register now